Enomoto T, Weghorst C M, Ward J M, Anderson L M, Perantoni A O, Rice J M
Laboratory of Comparative Carcinogenesis, National Cancer Institute, Frederick, MD 21702-1201.
Carcinogenesis. 1993 Sep;14(9):1939-44. doi: 10.1093/carcin/14.9.1939.
Previous reports from several laboratories have consistently shown that approximately 30% of spontaneous hepatocellular adenomas and 70-80% of spontaneous hepatocellular carcinomas found in aged B6C3F1 [C57BL/6 (liver tumor resistant) x C3H (liver tumor susceptible)] male mice contain one of three missense point mutations in codon 61 of the H-ras oncogene, CAA-->AAA, CGA or CTA. Irrespective of subline, the C3H mouse, the paternal parent strain of the B6C3F1 hybrid, is more susceptible to spontaneous liver tumorigenesis than the B6C3F1 mouse. However, the role of H-ras in the pathogenesis of hepatocellular tumors in C3H mice is less clear, as widely different frequencies of activation of this gene, but by the same point mutations in codon 61, have been reported by various laboratories. The present study was undertaken to characterize H-ras involvement in hepatocellular tumors of aged C3H/He mice from the NCI-Frederick Cancer Research and Development Center Colony (C3H/HeNCr). Oncogene activation was evaluated in 45 C3H/HeNCr hepatocellular tumors by the NIH 3T3 transfection assays, and point mutations in the H-ras oncogene were detected and characterized in DNA fragments amplified by PCR, using dot blot hybridization analysis with mutation-specific oligonucleotide probes and direct dideoxy sequencing of PCR products. The only transforming gene detected in these tumors by NIH 3T3 transfection was H-ras. Only 17% (1/6) of spontaneous carcinomas and 8% (3/39) of spontaneous adenomas contained transforming H-ras sequences, each with a point mutation in codon 61. In all four cases with H-ras mutations, mutated sequences comprised a minor fraction of total H-ras gene copies in DNA extracted from primary tumors. H-ras mutations thus appear to have arisen relatively late in the pathogenesis of the neoplasms. For comparison, sections of formalin-fixed, paraffin-embedded hepatocellular tumors that occurred in untreated B6C3F1 hybrid mice sired by C3H/HeNCr males were assayed for the same H-ras mutations by PCR and dot blot hybridization. Nine of 13 such tumors (4/6 carcinomas, 5/7 adenomas) were positive. The overall difference in frequency of H-ras codon 61 mutations in hepatocellular tumors in C3H/HeNCr (4/45) versus B6C3F1 (9/13) was highly significant (P = 0.000035, Fisher's exact test). These data indicate that point mutations in H-ras do not generally play a major or an initiating role in spontaneous hepatocarcinogenesis of inbred C3H/HeNCr mice and contrast with the high rate of ras mutations in liver tumors of the B6C3F1 hybrid.
几个实验室之前的报告一致表明,在老年B6C3F1[C57BL/6(肝脏肿瘤抗性)×C3H(肝脏肿瘤易感性)]雄性小鼠中发现的约30%的自发性肝细胞腺瘤和70 - 80%的自发性肝细胞癌,其H-ras癌基因第61密码子存在三种错义点突变之一,即CAA→AAA、CGA或CTA。不论亚系如何,B6C3F1杂种的父本菌株C3H小鼠比B6C3F1小鼠更易发生自发性肝脏肿瘤。然而,H-ras在C3H小鼠肝细胞肿瘤发病机制中的作用尚不清楚,因为不同实验室报告该基因的激活频率差异很大,但均为第61密码子的相同点突变。本研究旨在表征H-ras在来自NCI-弗雷德里克癌症研究与发展中心群落(C3H/HeNCr)的老年C3H/He小鼠肝细胞肿瘤中的参与情况。通过NIH 3T3转染试验评估了45个C3H/HeNCr肝细胞肿瘤中的癌基因激活情况,并使用突变特异性寡核苷酸探针的点杂交分析和PCR产物的直接双脱氧测序,在通过PCR扩增的DNA片段中检测并表征了H-ras癌基因中的点突变。通过NIH 3T3转染在这些肿瘤中检测到的唯一转化基因是H-ras。只有17%(1/6)的自发性癌和8%(3/39)的自发性腺瘤含有转化型H-ras序列,每个序列在第61密码子处都有一个点突变。在所有4例H-ras突变病例中,突变序列在从原发性肿瘤提取的DNA中仅占总H-ras基因拷贝的一小部分。因此,H-ras突变似乎在肿瘤发病机制中出现得相对较晚。作为比较,通过PCR和点杂交分析,对由C3H/HeNCr雄性小鼠所生的未经处理的B6C3F1杂种小鼠中发生的福尔马林固定、石蜡包埋的肝细胞肿瘤切片进行了相同的H-ras突变检测。13个这样的肿瘤中有9个(4/6癌,5/7腺瘤)呈阳性。C3H/HeNCr(4/45)与B6C3F1(9/13)肝细胞肿瘤中H-ras第61密码子突变频率的总体差异非常显著(P = 0.000035,Fisher精确检验)。这些数据表明,H-ras中的点突变通常在近交系C3H/HeNCr小鼠的自发性肝癌发生中不发挥主要或起始作用,这与B6C3F1杂种小鼠肝脏肿瘤中高频率的ras突变形成对比。